HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Engleman, H M Articles by Douglas, N J Search for Related Content PubMed PubMed Citation Articles by Engleman, H M Articles by Douglas, N J

Sleep · 4: Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/hypopnoea syndrome

Edinburgh Sleep Centre, Unit of Respiratory Medicine, University of Edinburgh, UK

Correspondence to:
Correspondence to:
Dr H M Engleman
Edinburgh Sleep Centre, Royal Infirmary of Edinburgh, Lauriston Place, Edinburgh EH3 9YW, UK; h.engleman{at}ed.ac.uk

Sleepiness, cognitive performance, and quality of life are overlapping aspects of daytime function that may be affected in patients with obstructive sleep apnoea/hypopnoea syndrome. The evidence is compatible with hypotheses that these deficits are reversible with treatment, particularly for patients with severe disease.

Abbreviations: AHI, apnoea + hypopnoea index; CPAP, continuous positive airway pressure; FOSQ, functional outcomes of sleepiness questionnaire; HADS, hospital anxiety and depression scale; MSLT, multiple sleep latency test; MWT, maintenance of wakefulness test; NHP, Nottingham health profile; OSAHS, obstructive sleep apnoea/hypopnoea syndrome; OSLER, Oxford sleep resistance test; POMS, profile of mood states; SAQLI, sleep apnoea quality of life index

Keywords: obstructive sleep apnoea/hypopnoea syndrome; quality of life; cognitive function; sleepiness

This article has been cited by other articles:

				W. T. McNicholas Diagnosis of Obstructive Sleep Apnea in Adults Proceedings of the ATS, February 15, 2008; 5(2): 154 - 160. [Abstract] [Full Text] [PDF]

				W. T. McNicholas Cardiovascular outcomes of CPAP therapy in obstructive sleep apnea syndrome Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1666 - R1670. [Abstract] [Full Text] [PDF]

				I. Chakravorty, M. Shastry, and K. Farrington Sleep apnoea in end-stage renal disease: a short review of mechanisms and potential benefit from its treatment Nephrol. Dial. Transplant., January 1, 2007; 22(1): 28 - 31. [Full Text] [PDF]

				D S Hui, K W To, F W Ko, J P Fok, M C Chan, J C Ngai, A H Tung, C W Ho, M W Tong, C-C Szeto, et al. Nasal CPAP reduces systemic blood pressure in patients with obstructive sleep apnoea and mild sleepiness Thorax, December 1, 2006; 61(12): 1083 - 1090. [Abstract] [Full Text] [PDF]

				P. Elwood, M. Hack, J. Pickering, J. Hughes, and J. Gallacher Sleep disturbance, stroke, and heart disease events: evidence from the Caerphilly cohort J Epidemiol Community Health, January 1, 2006; 60(1): 69 - 73. [Abstract] [Full Text] [PDF]

				R Staats, P Stoll, D Zingler, J C Virchow, and M Lommatzsch Regulation of brain-derived neurotrophic factor (BDNF) during sleep apnoea treatment Thorax, August 1, 2005; 60(8): 688 - 692. [Abstract] [Full Text] [PDF]

				G.J. Gibson Obstructive sleep apnoea syndrome: underestimated and undertreated Br. Med. Bull., March 29, 2005; 72(1): 49 - 65. [Abstract] [Full Text] [PDF]

				J A Wedzicha, S L Johnston, and D M Mitchell Thorax annual report: 1 October 2003 to 30 September 2004 Thorax, December 1, 2004; 59(12): 1012 - 1015. [Full Text] [PDF]